Rosaline, living with Hereditary ATTR (hATTR) amyloidosis

  Рет қаралды 2,835

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Күн бұрын

This video was created for audiences in Ireland.
Rosaline, from Ireland, is living with Hereditary ATTR (hATTR) amyloidosis - an inherited, progressive disease caused by a genetic mutation that results in the misfolding of transthyretin (TTR) proteins. She discusses the impact of hATTR on her family, her life before her diagnosis and how she is living with the disease now.
TTR02-UKI-00171

Пікірлер
One family’s journey with hereditary TTR amyloidosis: Dan and Diana
6:40
Alnylam Pharmaceuticals
Рет қаралды 2,6 М.
David, living with Hereditary ATTR (hATTR) amyloidosis
3:20
Alnylam Pharmaceuticals
Рет қаралды 1,5 М.
Every team from the Bracket Buster! Who ya got? 😏
0:53
FailArmy Shorts
Рет қаралды 13 МЛН
John, living with Hereditary ATTR (hATTR) amyloidosis
3:54
Alnylam Pharmaceuticals
Рет қаралды 2,4 М.
Alicia - Living with Acute Hepatic Porphyria (AHP)
3:59
Alnylam Pharmaceuticals
Рет қаралды 289
Sue - Living with Acute Hepatic Porphyria (AHP)
4:05
Alnylam Pharmaceuticals
Рет қаралды 172
Pathophysiology of Acute Hepatic Porphyria (AHP)
3:34
Alnylam Pharmaceuticals
Рет қаралды 1,1 М.
RNAi Therapeutics - How this New Class of Medicines Works
3:27
Alnylam Pharmaceuticals
Рет қаралды 892
RNAi, vielversprechendes Potenzial für eine neue Klasse von Medikamenten
3:32
Alnylam Pharmaceuticals
Рет қаралды 1,1 М.
Isabelle, Atteinte de PHA
5:18
Alnylam Pharmaceuticals
Рет қаралды 103
What is an RNAi Therapeutic?
0:55
Alnylam Pharmaceuticals
Рет қаралды 543